A single molecule has been designed to hunt and kill brain cancer cells while simultaneously healing and protecting healthy neurons.
April 26, 2026
Original Paper
Dual Antitumor and Neuroprotective Activities of Lipid Ether Amide Hybrids in Glioma Cells and Metabolically Damaged Neurons
SSRN · 6636959
The Takeaway
Most cancer treatments are just as toxic to healthy cells as they are to the tumor. These lipid ether amide hybrids act as a targeted weapon that stops the growth of glioma stem cells. At the same time, the molecule acts as a rescue agent for nearby neurons that have been damaged by metabolic stress. It restores the physical architecture of healthy brain cells while the cancer is being destroyed. Finding one substance that can perform these two opposite tasks is a major breakthrough for treating aggressive brain tumors.
From the abstract
Background: Lipid metabolism and signaling via multiple receptors strongly influences the development of brain tumors and affects neuronal vulnerability and damage. Oleic and palmitic acids are endogenous ligands for the nuclear receptor TLX and the constitutively active G-Protein coupled receptors GPR3 and GPR6. TLX is overexpressed in glioma stem/progenitor cells and promotes tumor development, while GPR3 and GPR6 support neuronal survival and integrity. To exploit these pathways therapeutica